Abstract
Introduction. None of the multi-centre phase III randomized controlled trials (RCTs) performed in TBI have convincingly demonstrated efficacy. Problems in clinical trial design and analysis may have contributed to these failures. Clinical trials in the TBI population pose several complicated methodological challenges, related especially to the heterogeneity of the population. In this paper we examine the issue of heterogeneity within the IMPACT (International Mission on Prognosis and Clinical Trial design in TBI) database and investigate the application of conven tional and innovative methods for the statistical analysis of trials in TBI. Methods and results. Simulation studies in the IMPACT database (TV = 9205) showed substantial gains in efficiency with covariate adjustment. Adjusting for 7 important predictors yielded up to a 28% potential reduction in trial size. Ongoing analyses on the potential benefit of ordinal analysis, such as proportional odds and sliding dichotomy, gave promising results with even larger potential reductions in trial size. Conclusion. The statistical power of RCTs in TBI can be considerably increased by applying covariate adjustment and by ordinal analysis methods of the GOS. These methods need to be considered for optimizing future TBI trials.
The IMPACT Study Group is a collaborative venture including the division of Community Health Sciences, University of Edinburgh Scotland, The Department of Neurosurgeru Virginia Commonwealth University, Richmond, USA, The Center for Medical Decision Sciences, Department of Public Health, Erasmus MC, Rotterdam, The Netherlands and University Hospital Antwerp, Belgium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barer D Ecass ii (1999) Intravenous alteplase in acute ischaemic stroke. European co-operative acute stroke study — ii. Lancet 353: 66–67; author reply 67-68
Berman MF, Solomon RA, Mayer SA, et al (2003) Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 34: 2200–2207
Butcher I, Maas AI, Lu J, et al (2007) Prognostic value of admission blood pressure in traumatic brain injury: results from the impact study. J Neurotrauma 24: 294–302
Butcher I, McHugh GS, Lu J, et al (2007) Prognostic value of cause of injury in traumatic brain injury: results from the impact study. J Neurotrauma 24: 281–286
Choi SC (1998) Sample size in clinical trials with dichotomous endpoints: use of covariables. J Biopharm Stat 8: 367–375
Clifton GL, Miller ER, Choi SC, et al (2001) Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344: 556–563
Cooper DJ, Myles PS, McDermott FT, et al (2004) Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291: 1350–1357
Diringer MN, Edwards DF (2001) Admission to a neurologic/ neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 29: 635–640
Edwards P, Arango M, Balica L, et al (2005) Final results of mrc crash, a randomised placebo-controlled trial of intravenous corti-costeroid in adults with head injury-outcomes at 6 months. Lancet 365: 1957–1959
Hernandez AV, Steyerberg EW, Butcher I, et al (2006) Adjustment for strong predictors of outcome in traumatic brain injury trials: 25% reduction in sample size requirements in the impact study. J Neurotrauma 23: 1295–1303
Hernandez AV, Steyerberg EW, Habbema JD (2004) Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol 57: 454–460
Hukkelhoven CW, Steyerberg EW, Habbema JD, et al (2005) Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J Neurotrauma 22: 1025–1039
Hukkelhoven CW, Steyerberg EW, Farace E, et al (2002) Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials. J Neurosurg 97: 549–557
Maas AI, Steyerberg EW, Murray GD, et al (1999) Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations. Neurosurgery 44: 1286–1298
Maas AI, Steyerberg EW, Butcher I, et al (2007) Prognostic value of computerized tomography scan characteristics in traumatic brain injury: results from the impact study. J Neurotrauma 24: 303–314
Maas AI, Murray G, Henney H, et al (2006) Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase iii randomised, placebo-controlled, clinical trial. Lancet Neurol 5: 38–45
Machado SG, Murray GD, Teasdale GM (1999) Evaluation of designs for clinical trials of neuroprotective agents in head injury. European brain injury consortium. J Neurotrauma 16: 1131–1138
Marmarou A, Lu J, Butcher I, et al (2007) Impact database of traumatic brain injury: design and description. J Neurotrauma 24: 239–250
Marmarou A, Lu J, Butcher I, et al (2007) Prognostic value of the glasgow coma scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an impact analysis. J Neurotrauma 24: 270–280
McHugh GS, Butcher I, Steyerberg EW, et al (2007) Statistical approaches to the univariate prognostic analysis of the impact database on traumatic brain injury. J Neurotrauma 24: 251–258
McHugh GS, Engel DC, Butcher I, et al (2007) Prognostic value of secondary insults in traumatic brain injury: results from the impact study. J Neurotrauma 24: 287–293
Murray GD, Barer D, Choi S, et al (2005) Design and analysis of phase iii trials with ordered outcome scales: the concept of the sliding dichotomy. J Neurotrauma 22: 511–517
Murray GD, Butcher I, McHugh GS, et al (2007) Multivariable prognostic analysis in traumatic brain injury: results from the impact study. J Neurotrauma 24: 329–337
Mushkudiani NA, Engel DC, Steyerberg EW, et al (2007) Prognostic value of demographic characteristics in traumatic brain injury: results from the impact study. J Neurotrauma 24: 259–269
Narayan RK, Michel ME, Ansell B, et al (2002) Clinical trials in head injury. J Neurotrauma 19: 503–557
Optimising Analysis of Stroke Trials C, Bath PM, Gray LJ, et al (2007) Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke 38: 1911–1915
Roberts I, Yates D, Sandercock P, et al (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (mrc crash trial): Randomised placebo-controlled trial. Lancet 364: 1321–1328
Von Steinbuechel N, Petersen C, Bullinger M, et al (2005) Assessment of health-related quality of life in persons after traumatic brain injury-development of the qolibri, a specific measure. Acta Neurochir Suppl 93: 43–49
Steyerberg EW, Bossuyt PM, Lee KL (2000) Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? Am Heart J 139: 745–751
Temkin NR, Anderson GD, Winn HR, et al (2007) Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6: 29–38
Van Beek JG, Mushkudiani NA, Steyerberg EW, et al (2007) Prognostic value of admission laboratory parameters in traumatic brain injury: results from the impact study. J Neurotrauma 24: 315–328
Wilson JT, Pettigrew LE, Teasdale GM (1998) Structured interviews for the glasgow outcome scale and the extended glasgow outcome scale: guidelines for their use. J Neurotrauma 15: 573–585
Wilson JT, Slieker FJ, Legrand V, et al (2007) Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trial. Neurosurgery 61: 123–128; discussion 128-129
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag
About this paper
Cite this paper
Maas, A.I.R., Lingsma, H.F., IMPACT study group. (2008). New approaches to increase statistical power in TBI trials: Insights from the IMPACT study. In: Chiu, WT., et al. Reconstructive Neurosurgery. Acta Neurochirurgica Supplementum, vol 101. Springer, Vienna. https://doi.org/10.1007/978-3-211-78205-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-211-78205-7_20
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-78204-0
Online ISBN: 978-3-211-78205-7
eBook Packages: MedicineMedicine (R0)